Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis
Gespeichert in:
| Veröffentlicht in: | Functional neurology 2001-04, Vol.16 (2), p.117-128 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 128 |
|---|---|
| container_issue | 2 |
| container_start_page | 117 |
| container_title | Functional neurology |
| container_volume | 16 |
| creator | HOROWSKI, Reinhard STÜRZEBECHER, Claus-Steffen KAPP, Joachim-Friedrich |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71070082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71070082</sourcerecordid><originalsourceid>FETCH-LOGICAL-p236t-7d7344274822b082f848bc0c8edb20728e82ccd5de4804c96bef253dbea4959b3</originalsourceid><addsrcrecordid>eNpF0EtLAzEUBeAgiq3VvyBZiOhiIK9pMstWfEGpi-p6yOOORjIPk8yi_noHrLi6cPg4HO4RmtNK0oIzKY7RnPCKFyVbihk6S-mTkJJzQU7RjFJRlYLKOdptYcxRB__tu3esu-xN7zwkfLNdrXe3U-Kw7zLEBmLfYQNZF3SN8wdEPexx3-B2DNkPAXCyYTLJp3N00uiQ4OJwF-jt4f717qnYvDw-3602xcD4MhfSSS7EtFQxZohijRLKWGIVOMOIZAoUs9aVDoQiwlZLAw0ruTOgp_WV4Qt0_ds7xP5rhJTr1icLIegO-jHVkhJJpuIJXh7gaFpw9RB9q-O-_nvDBK4OQCerQxN1Z336d6QUQij-A0INZlg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71070082</pqid></control><display><type>article</type><title>Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>HOROWSKI, Reinhard ; STÜRZEBECHER, Claus-Steffen ; KAPP, Joachim-Friedrich</creator><creatorcontrib>HOROWSKI, Reinhard ; STÜRZEBECHER, Claus-Steffen ; KAPP, Joachim-Friedrich</creatorcontrib><identifier>ISSN: 0393-5264</identifier><identifier>EISSN: 1971-3274</identifier><identifier>PMID: 11495417</identifier><language>eng</language><publisher>Roma: CIC Edizioni internazionali</publisher><subject>Adjuvants, Immunologic - therapeutic use ; Antibodies - analysis ; Antibodies - immunology ; Antibody Formation ; Biological and medical sciences ; Cross-Sectional Studies ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; Humans ; Interferon beta-1a ; Interferon beta-1b ; Interferon-beta - immunology ; Interferon-beta - therapeutic use ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Multiple Sclerosis - drug therapy ; Multiple Sclerosis - immunology ; Neutralization Tests ; Pharmacology. Drug treatments ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Functional neurology, 2001-04, Vol.16 (2), p.117-128</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1054448$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11495417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HOROWSKI, Reinhard</creatorcontrib><creatorcontrib>STÜRZEBECHER, Claus-Steffen</creatorcontrib><creatorcontrib>KAPP, Joachim-Friedrich</creatorcontrib><title>Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis</title><title>Functional neurology</title><addtitle>Funct Neurol</addtitle><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Antibodies - analysis</subject><subject>Antibodies - immunology</subject><subject>Antibody Formation</subject><subject>Biological and medical sciences</subject><subject>Cross-Sectional Studies</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Humans</subject><subject>Interferon beta-1a</subject><subject>Interferon beta-1b</subject><subject>Interferon-beta - immunology</subject><subject>Interferon-beta - therapeutic use</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Multiple Sclerosis - immunology</subject><subject>Neutralization Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0393-5264</issn><issn>1971-3274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0EtLAzEUBeAgiq3VvyBZiOhiIK9pMstWfEGpi-p6yOOORjIPk8yi_noHrLi6cPg4HO4RmtNK0oIzKY7RnPCKFyVbihk6S-mTkJJzQU7RjFJRlYLKOdptYcxRB__tu3esu-xN7zwkfLNdrXe3U-Kw7zLEBmLfYQNZF3SN8wdEPexx3-B2DNkPAXCyYTLJp3N00uiQ4OJwF-jt4f717qnYvDw-3602xcD4MhfSSS7EtFQxZohijRLKWGIVOMOIZAoUs9aVDoQiwlZLAw0ruTOgp_WV4Qt0_ds7xP5rhJTr1icLIegO-jHVkhJJpuIJXh7gaFpw9RB9q-O-_nvDBK4OQCerQxN1Z336d6QUQij-A0INZlg</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>HOROWSKI, Reinhard</creator><creator>STÜRZEBECHER, Claus-Steffen</creator><creator>KAPP, Joachim-Friedrich</creator><general>CIC Edizioni internazionali</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis</title><author>HOROWSKI, Reinhard ; STÜRZEBECHER, Claus-Steffen ; KAPP, Joachim-Friedrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p236t-7d7344274822b082f848bc0c8edb20728e82ccd5de4804c96bef253dbea4959b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Antibodies - analysis</topic><topic>Antibodies - immunology</topic><topic>Antibody Formation</topic><topic>Biological and medical sciences</topic><topic>Cross-Sectional Studies</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Humans</topic><topic>Interferon beta-1a</topic><topic>Interferon beta-1b</topic><topic>Interferon-beta - immunology</topic><topic>Interferon-beta - therapeutic use</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Multiple Sclerosis - immunology</topic><topic>Neutralization Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOROWSKI, Reinhard</creatorcontrib><creatorcontrib>STÜRZEBECHER, Claus-Steffen</creatorcontrib><creatorcontrib>KAPP, Joachim-Friedrich</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Functional neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOROWSKI, Reinhard</au><au>STÜRZEBECHER, Claus-Steffen</au><au>KAPP, Joachim-Friedrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis</atitle><jtitle>Functional neurology</jtitle><addtitle>Funct Neurol</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>16</volume><issue>2</issue><spage>117</spage><epage>128</epage><pages>117-128</pages><issn>0393-5264</issn><eissn>1971-3274</eissn><cop>Roma</cop><pub>CIC Edizioni internazionali</pub><pmid>11495417</pmid><tpages>12</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0393-5264 |
| ispartof | Functional neurology, 2001-04, Vol.16 (2), p.117-128 |
| issn | 0393-5264 1971-3274 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71070082 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adjuvants, Immunologic - therapeutic use Antibodies - analysis Antibodies - immunology Antibody Formation Biological and medical sciences Cross-Sectional Studies Dose-Response Relationship, Drug Drug toxicity and drugs side effects treatment Humans Interferon beta-1a Interferon beta-1b Interferon-beta - immunology Interferon-beta - therapeutic use Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Multiple Sclerosis - drug therapy Multiple Sclerosis - immunology Neutralization Tests Pharmacology. Drug treatments Retrospective Studies Treatment Outcome |
| title | Neutralizing antibodies (NABS) and interferon beta-1B therapy of multiple sclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A33%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutralizing%20antibodies%20(NABS)%20and%20interferon%20beta-1B%20therapy%20of%20multiple%20sclerosis&rft.jtitle=Functional%20neurology&rft.au=HOROWSKI,%20Reinhard&rft.date=2001-04-01&rft.volume=16&rft.issue=2&rft.spage=117&rft.epage=128&rft.pages=117-128&rft.issn=0393-5264&rft.eissn=1971-3274&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71070082%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71070082&rft_id=info:pmid/11495417&rfr_iscdi=true |